Cargando…
Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls – PRO-CARDIO-C study
AIM OF THE STUDY: Ongoing national screening programmes suggest that the prevalence of chronic hepatitis C (CHC) in Poland ranges between 0.5% and 1%. It has been recently noted that patients with confirmed coronary artery disease may be at higher risk for hepatitis C virus (HCV) infection. MATERIAL...
Autores principales: | Piekarska, Anna, Mamzer-Dachnowska, Aleksandra, Kasprzak, Jarosław D., Peruga, Jan Z., Kaszuba, Andrzej, Berkan-Kawińska, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728861/ https://www.ncbi.nlm.nih.gov/pubmed/31501787 http://dx.doi.org/10.5114/ceh.2019.84782 |
Ejemplares similares
-
Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population
por: Piekarska, Anna, et al.
Publicado: (2016) -
The prevalence and severity of 25-(OH)-vitamin D insufficiency in HCV infected and in HBV infected patients: a prospective study
por: Berkan-Kawińska, Aleksandra, et al.
Publicado: (2015) -
Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report
por: Piekarska, Anna, et al.
Publicado: (2020) -
Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection
por: Jabłonowska, Elżbieta, et al.
Publicado: (2013) -
Multifunctional CD40L: pro- and anti-neoplastic activity
por: Korniluk, Aleksandra, et al.
Publicado: (2014)